A Novel Tight Junction–Nuclear Receptor Signaling Pathway Regulating Cancer Progression
Pathology International · 2025
DOI: 10.1111/pin.70040 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift Pathology International, 2025. Verfasst von Kotaro Sugimoto und 1 weiteren Autor:innen. Beteiligte Einrichtung: Department of Basic Pathology, Fukushima Medical University School of Medicine, Fukushima, Japan. Hauptthemen laut MEDLINE: Signal Transduction, Neoplasms, Tight Junctions, Receptors, Cytoplasmic and Nuclear. Die Arbeit nennt 80 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0). Gefördert von: The authors received no specific funding for this work..
Abstract (Originalsprache)
Nuclear receptors (NRs) are lipid ligand‐binding transcription factors, with 48 members having been identified in humans to date. They are involved in diverse physiological processes, including development and homeostasis, and are also implicated in the pathogenesis of various diseases, most notably cancer. While NR activity is primarily regulated by specific ligand binding, posttranslational modifications, particularly phosphorylation, also play a critical role in modulating their function. Recently, we identified a novel signaling pathway linking claudins (CLDNs), cell‐cell adhesion proteins, to NRs. CLDN‐mediated cell‐cell adhesion activates Src family kinases (SFKs), leading to serine phosphorylation of several NRs. This newly‐discovered CLDN–NR pathway contributes to epithelial differentiation in stem cells and promotes cancer progression. In this review, we discuss the biological significance and underlying mechanisms of this, tracing the development of our research.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Basic Pathology, Fukushima Medical University School of Medicine, Fukushima, Japan.
- Department of Pathology, Sapporo Medical University School of Medicine, Sapporo, Japan.
ORCID-Profile: Kotaro Sugimoto, Hideki Chiba
Förderung
- The authors received no specific funding for this work.
Zitieren
APA
Sugimoto, K., & Chiba, H. (2025). A Novel Tight Junction–Nuclear Receptor Signaling Pathway Regulating Cancer Progression. Pathology International. https://doi.org/10.1111/pin.70040
Vancouver
Sugimoto K, Chiba H. A Novel Tight Junction–Nuclear Receptor Signaling Pathway Regulating Cancer Progression. Pathology International. 2025. doi:10.1111/pin.70040
BibTeX
@article{Sugimoto2025,
author = {Sugimoto, Kotaro and Chiba, Hideki},
title = {A Novel Tight Junction–Nuclear Receptor Signaling Pathway Regulating Cancer Progression},
journal = {Pathology International},
year = {2025},
doi = {10.1111/pin.70040}
}
EUVIMED